Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS
PHASE4CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
March 31, 2015
Primary Completion Date
June 30, 2015
Study Completion Date
July 31, 2015
Conditions
Polycystic Ovary SyndromeInsulin Resistance
Interventions
DRUG
Vipdomet
DRUG
Incresync
Trial Locations (1)
1000
University Medical Center Ljubljana, Ljubljana
All Listed Sponsors
lead
University Medical Centre Ljubljana
OTHER
NCT02683226 - Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS | Biotech Hunter | Biotech Hunter